Inflammation occurs early during the Aβ deposition process in TgCRND8 mice

Neurobiology of Aging

Volumn 25, Issue 7, 2004, Pages 861-871

  Dudal, Sherri ^a   Krzywkowski, Pascale ^b   Paquette, Julie ^b   Morissette, Céline ^b   Lacombe, Diane ^b   Tremblay, Patrick ^b   Gervais, Francine ^a,b,c  

^a MCGILL UNIVERSITY   (Canada)

^b Neurochem Inc   (Canada)

^c Neurochem Inc   (Canada)

Author keywords

A deposition; Alzheimer's disease; Inflammation; Morphometry; Transgenic mouse model

Indexed keywords

AMYLOID BETA PROTEIN; GENE PRODUCT;

ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; DISEASE COURSE; GENE CLUSTER; GENE MUTATION; HIPPOCAMPUS; IMMUNOCOMPETENT CELL; INFLAMMATION; INFLAMMATORY CELL; KINETICS; MICROGLIA; MOUSE; NEOCORTEX; NONHUMAN; PLAQUE FORMING CELL; PRIORITY JOURNAL; PROTEIN DEPLETION; THALAMUS; TIMED DRUG RELEASE; TRANSGENIC MOUSE;

AGE FACTORS; ALZHEIMER DISEASE; AMYGDALA; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANTIGENS, CD11B; BRAIN; DISEASE MODELS, ANIMAL; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROGLIA; NEOCORTEX; SENILE PLAQUES; THIAZOLES;

EID: 3042567711     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2003.08.008     Document Type: Article

References (63)

1. Akiyama H., Arai T., Kondo H., Tanno E., Haga C., Ikeda K. Cell mediators of inflammation in the Alzheimer disease brain. Alzheimer Dis. Assoc. Disord. 14(Suppl. 1):2000;S47-S53
2. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., et al. Inflammation and Alzheimer's disease. Neurobiol. Aging. 21:2000;383-421
3. Apelt J., Schliebs R. β-Amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology. Brain Res. 894:2001;21-30
4. Arendash G.W., King D.L., Gordon M.N., Morgan D., Hatcher J.M., Hope C.E., et al. Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res. 891:2001;42-53
5. Armstrong R.A., Myers D., Smith C.U. Alzheimer's disease: size class frequency distribution of senile plaques: do they indicate when a brain tissue was affected? Neurosci. Lett. 127:1991;223-226
6. Armstrong R.A. β-Amyloid plaques: stages in life history or independent origin? Dement. Geriatr. Cogn. Disord. 9:1998;227-238
7. Bales K.R., Verina T., Cummins D.J., Du Y., Dodel R.C., Saura J., et al. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 96:1999;15233-15238
8. Bales K.R., Du Y., Holtzman D., Cordell B., Paul S.M. Neuroinflammation and Alzheimer's disease: critical roles for cytokine/Aβ-induced glial activation, NF-κB and apolipoprotein E. Neurobiol. Aging. 21:2000;427-432
9. Benzing W.C., Wujek J.R., Ward E.K., Shaffer D., Ashe K.H., Younkin S.G., et al. Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice. Neurobiol. Aging. 20:1999;581-589
10. Berg L., McKeel D.W. Jr., Miller J.P., Baty J., Morris J.C. Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older. Arch. Neurol. 50:1993;349-358
11. Borchelt D.R., Ratovitski T., Van Lare J., Lee M.K., Gonzales V., Jenkins N.A., et al. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron. 19:1997;939-945
12. Buttini M., Orth M., Bellosta S., Akeefe H., Pitas R.E., Wyss-Coray T., et al. Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration. J. Neurosci. 19:1999;4867-4880
13. Calhoun M.E., Burgermeister P., Phinney A.L., Stalder M., Tolnay M., Wiederhold K.H., et al. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc. Natl. Acad. Sci. U.S.A. 96:1999;14088-14093
14. Carlson G.A., Borchelt D.R., Dake A., Turner S., Danielson V., Coffin J.D., et al. Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice. Hum. Mol. Genet. 6:1997;1951-1959
15. Chishti M.A., Yang D.S., Janus C., Phinney A.L., Horne P., Pearson J., Strome R., Zuker N., Loukides J., French J., Turner S., Lozza G., Grilli M., Kunicki S., Morissette C., Paquette J., Gervais F., Bergeron C., Fraser P.E., Carlson G.A., George-Hyslop P.S., Westaway D. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J. Biol. Chem. 276:2001;21562-21570
16. Citron M., Oltersdorf T., Haass C., McConlogue L., Hung A.Y., Seubert P., et al. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature. 360:1992;672-674
17. Cotman C.W., Tenner A.J., Cummings B.J. β-Amyloid converts an acute phase injury response to chronic injury responses. Neurobiol. Aging. 17:1996;723-731
18. Das S., Potter H. Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1. Neuron. 14:1995;447-456
19. Dickson D.W. Microglia in Alzheimer's disease and transgenic models. How close the fit? Am. J. Pathol. 154:1999;1627-1631
20. Dodart J.C., Meziane H., Mathis C., Bales K.R., Paul S.M., Ungerer A. Behavioral disturbances in transgenic mice overexpressing the V717F β-amyloid precursor protein. Behav. Neurosci. 113:1999;982-990
21. Franklin KBJ, Paxinos G. The mouse brain in stereotaxic coordinates. San Diego: Academic Press; 1997.
22. Fujita S.C., Sakuta K., Tsuchiya R., Hamanaka H. Apolipoprotein E is found in astrocytes but not in microglia in the normal mouse brain. Neurosci. Res. 35:1999;123-133
23. Fukumoto H., Asami-Odaka A., Suzuki N., Shimada H., Ihara Y., Iwatsubo T. Amyloid β protein deposition in normal aging has the same characteristics as that in Alzheimer's disease. Predominance of Aβ42(43) and association of Aβ40 with cored plaques. Am. J. Pathol. 148:1996;259-265
24. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature. 373:1995;523-527
25. Gouras G.K., Tsai J., Naslund J., Vincent B., Edgar M., Checler F., et al. Intraneuronal Aβ42 accumulation in human brain. Am. J. Pathol. 156:2000;15-20
26. Griffin W.S., Stanley L.C., Ling C., White L., MacLeod V., Perrot L.J., et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 86:1989;7611-7615
27. Haass C., Baumeister R. What do we learn from a few familial Alzheimer's disease cases? J. Neural. Transm. 54(Suppl.):1998;137-145
28. Hock B.J., Lamb B.T. Transgenic mouse models of Alzheimer's disease. Trends Genet. 17:2001;S7-S12
29. Holcomb L., Gordon M.N., McGowan E., Yu X., Benkovic S., Jantzen P., et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat. Med. 4:1998;97-100
30. Holtzman D.M., Bales K.R., Tenkova T., Fagan A.M., Parsadanian M., Sartorius L.J., et al. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 97:2000;2892-2897
31. Holtzman D.M. Role of apoE/Aβ interactions in the pathologenesis of Alzheimer's disease and cerebral amyloid angiopathy. J. Mol. Neurosci. 17:2001;147-155
32. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., et al. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102
33. Hsiao K.K., Borchelt D.R., Olson K., Johannsdottir R., Kitt C., Yunis W., et al. Age related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron. 15:1995;1203-1218
34. Iwatsubo T., Mann D.M., Odaka A., Suzuki N., Ihara Y. Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Down syndrome. Ann. Neurol. 37:1995;294-299
35. Iwatsubo T., Saido T.C., Mann D.M., Lee V.M., Trojanowski J.Q. Full-length amyloid-β (1-42(43)) and amino-terminally modified and truncated amyloid-β 42(43) deposit in diffuse plaques. Am. J. Pathol. 149:1996;1823-1830
36. Jarrett J.T., Berger E.P., Lansbury P.T. Jr. The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry. 32:1993;4693-4697
37. Johnson-Wood K., Lee M., Motter R., Hu K., Gordon G., Barbour R., et al. Amyloid precursor protein processing and Aβ42 deposition in a transgenic mouse model of Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 94:1997;1550-1555
38. Kawarabayashi T., Younkin L.H., Saido T.C., Shoji M., Ashe K.H., Younkin S.G. Age-dependent changes in brain, CSF, and plasma amyloid β protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J. Neurosci. 21:2001;372-381
39. Kelly P.H., Bondolfi L., Hunziker D., Schlecht H.P., Carver K., Maguire E., et al. Progressive age-related impairment of cognitive behavior in APP23 transgenic mice. Neurobiol. Aging. 24:2003;365-378
40. Kuo Y.M., Beach T.G., Sue L.I., Scott S., Layne K.J., Kokjohn T.A., et al. The evolution of Aβ peptide burden in the APP23 transgenic mice: implications for Aβ deposition in Alzheimer's disease. Mol. Med. 7:2001;609-618
41. Kuo Y.M., Kokjohn T.A., Beach T.G., Sue L.I., Brune D., Lopez J.C., et al. Comparative analysis of amyloid-β chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains. J. Biol. Chem. 276:2001;12991-12998
42. Matsuoka Y., Picciano M., Malester B., LaFrancois J., Zehr C., Daeschner J.M., et al. Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease. Am. J. Pathol. 158:2001;1345-1354
43. McGeer P.L., Rogers J. Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology. 42:1992;447-449
44. McGeer P.L., Schulzer M., McGeer E.G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology. 47:1996;425-432
45. McGeer P.L., McGeer E.G. Inflammation, autotoxicity and Alzheimer's disease. Neurobiol. Aging. 22:2001;799-809
46. McGowan E., Sanders S., Iwatsubo T., Takeuchi A., Saido T., Zehr C., et al. Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes. Neurobiol. Dis. 6:1999;231-244
47. Mucke L., Masliah E., Yu G.Q., Mallory M., Rockenstein E.M., Tatsuno G., et al. High-level neuronal expression of Aβ1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20:2000;4050-4058
48. 1-antichymotrypsin enhances Alzheimer-like pathology in amyloid protein precursor transgenic mice. Am. J. Pathol. 157:2000;2003-2010
49. 1-Antichymotrypsin promotes β-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease. J. Neurosci. 21:2001;1444-1451
50. Perlmutter L.S., Barron E., Chui H.C. Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease. Neurosci. Lett. 119:1990;32-36
51. Qiao X., Cummins D.J., Paul S.M. Neuroinflammation-induced acceleration of amyloid deposition in the APPV717F transgenic mouse. Eur. J. Neurosci. 14:2001;474-482
52. Schmitteckert E.M., Prokop C.M., Hedrich H.J. DNA detection in hair of transgenic mice: a simple technique minimizing the distress on the animals. Lab. Anim. 33:1999;385-389
53. Selkoe D.J. The molecular pathology of Alzheimer's disease. Neuron. 6:1991;487-498
54. Sheng J.G., Mrak R.E., Griffin W.S.T. Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms. Acta Neuropathol. (Berl.). 94:1997;1-5
55. Stalder M., Phinney A., Probst A., Sommer B., Staufenbiel M., Jucker M. Association of microglia with amyloid plaques in brains of APP23 transgenic mice. Am. J. Pathol. 154:1999;1673-1684
56. Stalder M., Deller T., Staufenbiel M., Jucker M. 3D-Reconstruction of microglia and amyloid in APP23 transgenic mice: no evidence of intracellular amyloid. Neurobiol. Aging. 22:2001;427-434
57. Sturchler-Pierrat C., Abramowski D., Duke M., Wiederhold K.H., Mistl C., Rothacher S., et al. Two amyloid precursor protein transgenic mouse models with Alzheimer's disease-like pathology. Proc. Natl. Acad. Sci. U.S.A. 94:1997;13287-13292
58. 717) mutants. Science. 264:1994;1336-1340
59. Terai K., Iwai A., Kawabata S., Sasamata M., Miyata K., Yamaguchi T. Apolipoprotein E deposition and astrogliosis are associated with maturation of β-amyloid plaques in βAPPswe transgenic mouse: implications for the pathogenesis of Alzheimer's disease. Brain Res. 900:2001;48-56
60. Terai K., Iwai A., Kawabata S., Tasaki Y., Watanabe T., Miyata K., et al. β-Amyloid deposits in transgenic mice expressing human β-amyloid precursor protein have the same characteristics as those in Alzheimer's disease. Neuroscience. 104:2001;299-310
61. Wegiel J., Wang K., Imaki H., Rubenstein R., Wronska A., Osuchowski M., et al. The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice. Neurobiol. Aging. 22:2001;49-61
62. Wirths O., Multhaup G., Czech C., Blanchard V., Moussaoui S., Tremp G., et al. Intraneuronal Aβ accumulation precedes plaque formation in β-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci. Lett. 306:2001;116-120
63. Wyss-Coray T., Lin C., Yan F., Yu G.Q., Rohde M., McConlogue L., et al. TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice. Nat. Med. 7:2001;612-618